Related by context. All words. (Click for frequent words.) 86 Provides Guidance 81 Receives Favorable 80 Updates Guidance 80 Issues Statement Regarding 79 Receives Notification 78 Temporarily Suspends 78 Provides Update Regarding 78 Announces Stockholder Approval 77 Gets Subpoena 77 Delays Filing 77 Formalizes 77 Complies With 77 Announce Settlement 77 Submits Application 77 Revises Guidance 77 Extends Deadline 77 Receives Approval From 77 Announces Restatement 76 Confirms Receipt 76 Files Shelf Registration Statement 76 Reaches Settlement Agreement 76 Reconfirms 76 Net Loss Narrows 76 Board Authorizes 76 Panel Backs 76 Strongly Supports 76 Updates Status 76 Reach Settlement Agreement 76 Regains NASDAQ 76 Recommends Changes 76 Regains Full 76 Receives Subpoena 76 Q4 Loss Narrows 76 Obtains Approval 75 Issues Clarification 75 Receives Favorable Ruling 75 Hires Lobbyist 75 Terminates Contract 75 Announces Revised 75 Reaffirms Guidance 75 Receives Notification From 75 Receives NASDAQ 75 Proposes Changes 75 Explore Strategic Alternatives 75 Receives Notice From 75 Q1 Loss Widens 75 Panel Recommends 75 Subsidiary Files 75 Stays Neutral 75 Pending Acquisition 75 Posts Wider Loss 75 Settles Charges 75 Lowers Guidance 75 Resubmits 75 Q2 Loss Narrows 75 Expects Higher 75 Completes Conversion 75 Provides Updated 75 Submits Proposal 75 Stock Soars 74 Panel Endorses 74 Announces Organizational Changes 74 Applauds Passage 74 Wins Approval 74 Releases Findings 74 Files Shelf Registration 74 Guidance Quick Facts 74 Refile 74 Delivers Strong 74 Report Indicates 74 Q4 Loss Widens 74 Receives Clearance From 74 Delay Filing 74 Seeks Approval 74 Q1 Loss Narrows 74 Regains Compliance With 74 Reach Settlement 74 Regains Compliance 74 Files Petition 74 Holds Hearing 74 Completes Transition 74 Shareholder Sues 74 Announce Receipt 74 Seeks Delay 74 Restate Results 74 Re Affirms 74 4Q Profit Surges 74 Regains Nasdaq 74 Provides Preliminary 74 Announces Favorable 74 Underscores Need 74 Expands Scope 74 Posts Narrower Loss 74 Q3 Loss Narrows 74 Receives Commitment 74 Q4 Profit Plunges 74 Announces Dismissal 74 Completes Divestiture 74 Provides Updates 74 Announces Effective Date 74 Forecast Quick Facts 74 Subsidiary Receives 74 Senate Panel Approves 74 Restate Earnings 74 Reduces Risk 74 Q2 Loss Widens 74 Jumps Higher 74 Posts Solid 73 Reduces Debt 73 Q1 Adj 73 Clears Path 73 Reschedules Fourth Quarter 73 Receives Notice 73 Revenues Decline 73 Files Annual Report 73 Shares Plummet 73 Reaches Tentative Settlement 73 Approves Merger 73 Panel Considers 73 3Q Loss Narrows 73 Issues Reminder 73 Audit Faults 73 Receives Regulatory Approvals 73 Restates 73 Reaches Settlement 73 Issues Statement 73 Expresses Disappointment 73 Restricts Access 73 Recommends Approval 73 Report Cites 73 Announce Expiration 73 Announces Discontinuation 73 Q3 Profit Surges 73 Narrows Guidance 73 Announces Resumption 73 Completes Tender Offer 73 Stockholders Approve Acquisition 73 Deadline Approaches 73 Q4 Adj 73 Q4 Profit Surges 73 Q1 Profit Declines 73 Extends Maturity 73 Q2 Adj 73 Announces Delisting 73 Announces Enhancements 73 Approve Merger 73 Announcement Regarding 73 Q2 Profit Surges 73 Complaint Filed 73 Scrutinizes 73 Achieves Milestone 73 Completes Merger With 73 Reaffirms Outlook 73 STERIS Corporation Announces 73 Panel Urges 73 Up Sharply 73 Univest Corporation Declares 73 Q3 Loss Widens 73 Legislation Introduced 73 Restate Financial 73 Announces Share Repurchase 73 Reaches Settlement With 73 Lowers Outlook 73 Releases Second Quarter 73 Emphasizes Need 73 Outlook Quick Facts 73 Remains Neutral 73 Maintains Strong 73 Releases Statement Regarding 73 Extends Tender Offer 73 More Than Doubled 73 Raises Guidance 73 Shares Soar 73 Significantly Increases 73 Boosts Buyback 73 Extends Offer 73 Receives Unsolicited 73 Deadline Approaching 73 Lowers Q4 73 Reports Receipt 73 Clears Way 73 Modifies 73 Reports Significantly Improved 73 Earnings Decline 73 Statement Regarding 73 Jointly Announce 73 Announces Preliminary 73 Panel Rejects 73 Expands Capabilities 72 4Q Loss Widens 72 Stock Plunges 72 Proposes Amendments 72 Hold Third Quarter 72 Receives Delisting Notice 72 Provides Clarification 72 Q1 Profit Soars 72 CorVel Announces 72 Announces Termination 72 Sees Decline 72 Board Unanimously Rejects 72 Completes Integration 72 1Q Loss Narrows 72 Receives Notice Regarding 72 Sinks Lower 72 Remains Confident 72 CFO Resigns 72 Finalizes Sale 72 Nears Decision 72 Drops Sharply 72 Net Loss Widens 72 Holds Hearings 72 Guides Inline 72 Applauds Introduction 72 Notifies 72 Announces Receipt 72 Seeks Injunction Against 72 Gets Favorable 72 Receives Orphan Drug Designation 72 Announces Presentation 72 Posts Strong 72 Results Reflect 72 Lawsuit Filed Against 72 Above Estimates 72 Sees Continued 72 Seeks Input 72 Panel Mulls 72 TriCo Bancshares Announces 72 2Q Loss Widens 72 Submits NDA 72 Below Consensus 72 Registration Statement Declared Effective 72 Study Examines 72 Reiterates Guidance 72 More Than Doubles 72 Consummates 72 Shareholders Approve Acquisition 72 Gets Approval 72 Reports Profitable 72 Files Amended 72 Lawsuit Alleges 72 4Q Loss Narrows 72 Ups Guidance 72 Announce Successful Completion 72 Files Patent Application 72 Announces Favorable Ruling 72 Reports Positive 72 Q2 Profit Rises 72 Amends Agreement 72 Receives Confirmation 72 Investigation Relating 72 Revises Fourth Quarter 72 Investigates Possible 72 Nearly Triples 72 Sees Higher 72 Posts 3Q Profit 72 Panel Votes 72 Reclassifies 72 Formally Launches 72 Bodes Well 72 Raises PT 72 Restate Financials 72 Waiver Request 72 Demonstrates Significant 72 Q3 Profit Drops 72 Announces Repurchase 72 Takes Steps 72 Rejects Request 72 Extends Expiration Date 72 Alert Technicals Showing Bearish 72 Delays Decision 72 Receives Milestone Payment 72 Announces Profitable 72 Delivers Solid 72 Q1 Profit Drops 72 Revises Third Quarter 72 Panel Approves 71 Hold Fourth Quarter 71 Merger Approved 71 Holds Steady 71 Webcast Second Quarter 71 Posts Quarterly 71 Testifies Before 71 Drop Sharply 71 Resolves Dispute 71 Propose Changes 71 Q4 Profit Rises 71 Receives Delisting Notification 71 Q4 Profit Soars 71 Q1 Profit Rises 71 Outlines Strategy 71 Q3 Adj 71 Publicizes 71 PPD Declares 71 Realigns 71 Tightens Rules 71 Achieves Positive 71 Expand Relationship 71 Subsidiary Awarded 71 Deadline Extended 71 Provide Comprehensive 71 FDA Panel Recommends 71 Declares Increase 71 Announces Successful Completion 71 Announces Postponement 71 Releases Third Quarter 71 Restates Earnings 71 1Q Profit Falls 71 Reaches Pact 71 Q2 Profit Drops 71 Q4 Profit Declines 71 Strengthens Balance Sheet 71 Rises Quick Facts 71 Guides Q4 71 Seeks Proposals 71 Stockholders Approve 71 Successfully Concludes 71 Launches Redesigned Website 71 Raises Concerns About 71 Renegotiates 71 Suit Seeks 71 Introduces Enhanced 71 Announce Completion 71 4Q Profit Jumps 71 Webcast Third Quarter 71 Receives Certification 71 Receives Positive 71 Completes Acquisitions 71 Sees Upside 71 Exceeds Estimates 71 Host Webcast 71 Urges Caution 71 Posts 4Q 71 Hold Hearings 71 Confirms Commitment 71 Successfully Completes Tender Offer 71 Posts Higher 71 Panel Advises 71 Announces Proposed Settlement 71 Withdraws Proposal 71 Flamel Technologies Announces 71 Nears Settlement 71 Narrows Loss 71 Announces Filing 71 Announce Commencement 71 Increases Share Repurchase 71 Validates 71 Sees Positive 71 Agreement Reached 71 Data Suggest 71 Licenses Patents 71 Affirms Commitment 71 Welcomes Analyst Initiation 71 4Q Profit Soars 71 3Q Profit Drops 71 Guides Q2 71 Sets Quarterly Dividend 71 Q2 Profit Plunges 71 Settlement Reached 71 1Q Loss Widens 71 Webcast Annual Meeting 71 Settles Litigation 71 Receives Approvable Letter 71 Issues Warning 71 3Q Profit Rises 71 Gets Clearance 71 Reaffirms Commitment 71 Receives Anticipated 71 Completes Buyout 71 Raises Outlook 71 Announces Divestiture 71 Panel Examines 71 Announce Launch 71 Shifts Focus 71 Refocuses 71 FY# Guidance 71 Announces Additions 71 Cuts Costs 71 Submits Response 71 Receives Authorization 71 Updates Shareholders 71 Celebrates Successful 71 Achieves Record Sales 71 Q2 Profit Declines 71 Authorizes Additional 71 Announces Cancellation 71 Receives Accreditation 71 Announces Intent 71 Investigates Claims 71 Announce Filing 71 Posts 4Q Profit 71 Achieves Significant 71 Pushes Back 71 Reports 4Q Loss 71 Record Third Quarter 71 Tops Expectations 71 Declares Preferred 71 4Q Profit Up 71 Achieves Highest 71 Panel Weighs 71 Sees Strong 71 Has Spiked 71 Submits Biologics License Application 71 Profit Dips 71 Sees Increase 71 Advisers Urge 71 PremierWest Bancorp Announces 71 Guides Above 71 Previously Announced 71 Discontinues 71 Settle Patent Dispute 71 Continues Aggressive 71 Sees 3Q 71 Awarded Contracts 71 Waiting Period 71 3Q Loss Widens 71 Declares Quarterly Dividends 71 Files Suit Against 71 Narrows 4Q Loss 71 Habersham Bancorp Announces 71 Files Lawsuit Against 71 Complete Merger 71 Announces Webcast 71 Seeks Nominations 71 Renews Agreement 71 Discloses 71 Receives Approvals 71 Q3 Profit Soars 71 More Than Triples 71 Settle Lawsuit Over 71 Completes Patient Enrollment 71 Completes Transaction 71 Q3 Profit Rises 71 Voluntarily Withdraw 71 Q3 Profit Declines 71 2Q Profit Surges 71 2Q Loss Narrows 71 Files Patent 71 Remains Committed 71 Posts 2Q 71 Attains 71 Settle Patent Litigation 71 Bearish Speculation 71 Previously Disclosed 71 Receives Clearance 70 Approves Sweeping 70 Bullish Speculation 70 Receives Conditional 70 Finalizes Purchase 70 Announces Quarterly 70 Awarded Patents 70 Testify Before 70 Announces Consummation 70 Sets Second Quarter 70 View Quick Facts 70 Groups Oppose 70 Increases Efficiency 70 Shareholders Approve Merger 70 Completes Reorganization 70 Receives Endorsement 70 Settle Lawsuits 70 Bearish MACD 70 Kaydon Corporation Announces 70 Selects Trintech 70 Revises Q3 70 Profit Leaps 70 Misses Views 70 Refines 70 Plans Buyback 70 Launches Enhanced 70 Withdraws Application 70 Curtails 70 Raises Concerns 70 Tops Estimate Update 70 Evaluate Strategic Alternatives 70 FDA Clears 70 Moves Towards 70 Being Investigated 70 Acknowledges Receipt 70 Regulators Approve 70 Tops Views 70 Secures Funding 70 Begins Tender Offer 70 Ups Dividend 70 Seeks Buyer 70 Posts 1Q 70 Groups Urge 70 Seek Shareholder Approval 70 Beats Forecast 70 Stockholders Approve Merger 70 Receives Approval 70 Earnings Postmortem 70 Reverses Course 70 Host Teleconference 70 Raise Questions 70 Reaffirms Fourth Quarter 70 Deadline Looms 70 Loss Shrinks 70 Profit Grows 70 Panel Upholds 70 Shares Tumble 70 Sees 1Q 70 Declares Increased 70 Posts Lower 70 Submits Supplemental 70 Receives Deficiency Letter 70 Could Harm 70 Activity Alert 70 Completes Restructuring 70 Approves Quarterly Dividend 70 Sees Wider 70 Announce Initiation 70 Receives Highest 70 Hearings Begin 70 Announces Effectiveness 70 Sees Possible 70 Bulks Up 70 Trims Loss 70 Increases Guidance 70 Hearing Scheduled 70 Introduces Next Generation 70 Appeals Court Upholds 70 Awarded Multi 70 Found Liable 70 Guides Below 70 Announces Stock Repurchase 70 Settle Charges 70 Enforcement Actions 70 Volume Spikes 70 Retools 70 Introduces Expanded 70 Subsidiary Wins 70 Announces Expanded 70 Conference Call TRANSCRIPT 70 Moving Average Crossover Alert 70 Completes Previously Announced 70 Exceeds Expectations 70 Reschedules 70 Posts Third Quarter 70 Host Fourth Quarter 70 Wins Summary Judgment 70 Files Registration Statement 70 Re Examine 70 Report Criticizes 70 Q1 Profit Surges 70 Momentum Continues 70 Lower Than Expected 70 Announces Departure 70 Lawsuit Seeks 70 Files Complaint Against 70 Completes Sale Of 70 Proposed Changes 70 Meets Expectations 70 1Q Profit Up 70 Delays Filing Annual Report 70 Announces Formation 70 Submits Revised 70 Clarifies Position 70 Increases Cash Dividend 70 Retains Leading 70 Reorganizes 70 Backs FY# Outlook 70 Q1 Profit Plunges 70 Reveals Positive 70 Losses Narrow 70 Enforces 70 Q4 Profit Drops 70 Q3 Profit Plunges 70 Schedules Second Quarter 70 Complies 70 Reaffirms Full 70 Hikes Dividend 70 Hold Second Quarter 70 Completes Purchase Of 70 Receives Complete Response 70 Schedules Fourth Quarter 70 Posts 1Q Profit 70 Holds Annual Meeting 70 Submits 70 Terminate Merger Agreement 70 Considers Extending 70 Lays Groundwork 70 Lowest Level 70 Releases Latest 70 Cites Positive 70 Meets Estimates 70 Rises Sharply 70 Generates Record 70 Restates Results 70 Announces Stock Buyback 70 Awarded Patent 70 Receives Patent 70 Q1 Profit Slips 70 Amends Credit 70 Leans Toward 70 Margin Expansion 70 Voluntarily Withdraws 70 Accepting Applications 70 Unanimously Approves 70 Ramping Up 70 Raises Quarterly Dividend 70 Reports Narrower Loss 70 Increases Quarterly Cash Dividend 70 Nears Deal 70 Announces Cash Dividend 70 Applauds Decision 70 Finalizes Acquisition 70 Calls Purchased 70 Reaffirms Earnings 70 Immunomedics Announces 70 Hails Passage 70 Earnings Rise 70 Can Proceed 70 2Q Profit Up 70 File Lawsuit Against 70 Amend Merger Agreement 70 Announces Appointments 70 Opposes Proposed 70 Completes Successful 70 Reaches Agreement 70 Results Disappoint 70 Increases Size 70 Initiates Clinical Trial 70 Settle Litigation 70 Complaint Filed Against 70 Updates Fourth Quarter 70 Provides Shareholder 70 Completes Refinancing 70 Announces Job Cuts 70 Completes Redemption 70 Granted Early Termination 70 Abandons Plans 70 Seeks Tougher 70 Marks Milestone 70 Lowers Rates 70 Reaffirms FY# Outlook 70 Settles Lawsuits 70 Could Trigger 70 Up Slightly 70 1Q Profit Down 70 4Q Profit Slides 70 Penalizes 70 Sharpens Focus 70 Profit Slips 70 Files Definitive Proxy 70 File Suit Against 70 Subsidiary Enters 70 Fourth Consecutive Year 70 Provides Tips 70 Licenses Novel 70 Lowers Forecast 70 Study Confirms 70 Contracts Awarded 70 Summarizes 70 Secures Long Term 70 Magazine Recognizes 70 Arthritis Drug 70 3Q Profit Jumps 70 Problems Persist 70 Be Delisted From 70 Reiterates Support 70 Experts Urge 70 Posts Loss 70 Moves Toward 70 Wider Than Expected 70 Earnings Surge 70 Submits Final 69 Advises Against 69 Lowers 4Q 69 CRWESelect CRWESelect.com Highlights 69 Judge Throws Out 69 Reinstates 69 Upholds 69 Unveils Enhanced 69 Gives Nod 69 Boosts Dividend 69 Unsolicited Proposal From 69 Demonstrates Commitment 69 Centralizes 69 Report Suggests 69 Guides Q1 69 Appoints Experienced 69 Tops Estimate 69 Settles Lawsuit 69 Profits Climb 69 Unanimously Recommends 69 Postpones Decision 69 Q1 Profit Decreases 69 Study Recommends 69 Guides Q3 69 Misled Investors 69 BIOLASE Announces 69 Sees Robust 69 Above Consensus 69 Announces Definitive Agreement 69 Successfully Completes Acquisition 69 Report Faults 69 Panel Finds 69 Announce Collaboration Agreement 69 Clarifies Status 69 Announces Publication 69 Gets Thumbs Down 69 Higher Than Expected 69 4Q Profit Down 69 Announces Initiation 69 NewsBite Downgrade Puts Pressure 69 House Panel Approves 69 Advises Caution 69 Revises Fiscal 69 Becomes Effective 69 4Q Profit Rises 69 Lifts FY# Outlook 69 Announces Refinancing 69 Announces Licensing Agreement 69 Suspends Dividend 69 Boosts Outlook 69 Lifts Dividend 69 Probe Finds 69 Helps Ensure 69 Stock Plummets 69 Below Estimates 69 Q3 Profit Slips 69 Bullish Average Crossover 69 Widens Quick Facts 69 Announces Proposed 69 Settle Suit Over 69 Shares Surge 69 Must Disclose 69 Enters Agreement 69 Guides FY# Quick Facts 69 Announce Early Termination 69 Files IND 69 Anounces 69 Extend Deadline 69 2Q Profit Soars 69 Post Earnings Checkup 69 Renews Commitment 69 Extends Commitment 69 Sell Itself 69 Issues Subpoenas 69 Completes Enrollment 69 Nasdaq Listing Requirements 69 Achieves Profitability 69 Vexes 69 Posts 2Q Loss 69 Posts 4Q Loss 69 4Q Profit Slips 69 Submits IND 69 Receives Stockholder Approval 69 Achieves Record 69 Expresses Concern About 69 Proposes Tougher 69 Guides FY# 69 Winning Streak Continues 69 Subsidiary Completes 69 Beat Estimates 69 Outlook Lowered 69 Significant Increase 69 Judge Clears Way 69 Taglich Brothers Initiates Coverage 69 Announce Licensing Agreement 69 1Q Profit Soars 69 Posts 2Q Profit 69 Beats Views 69 Announces Adjournment 69 Moves Forward 69 Clears Hurdle 69 Misses Expectations 69 Deadline Looming 69 Mulls Options 69 Successfully Completes 69 Panel Hears 69 Reports Fiscal 69 Closes Merger 69 4Q Profit Drops 69 Profit Sinks 69 Deadline Arrives 69 Warns Consumers 69 Results Confirm 69 Launches Next Generation 69 Finalizes 69 Holders Approve 69 Announce License Agreement 69 Sees 4Q 69 Shareholder Lawsuit 69 Completes Spin Off 69 Announces Issuance 69 Posts Profit 69 Irvine Sensors Releases 69 Beats Expectations 69 2Q Profit Climbs 69 Reaffirms Fiscal 69 Puts Spotlight 69 Suit Alleges 69 Quadruples 69 Provides Comprehensive 69 Emphasizes Importance 69 Plummets 69 Settle Dispute Over 69 Q4 Profit Jumps 69 Results Exceed Expectations 69 Lawsuit Settled 69 Significantly Reduces 69 Has Dropped 69 Acquires Controlling Interest 69 Exceed Estimates 69 Q4 Profit Slips 69 From Cont 69 Rejects Bid 69 Outlines Plans 69 Present Preclinical Data 69 Announces FDA Clearance 69 Significantly Improves 69 Q1 Profit Dips 69 Panel Debates 69 Concerns Raised 69 Announces Voluntary Delisting 69 Lawsuit Filed Over 69 Report Identifies 69 Gets Tougher 69 Feds Investigate 69 3Q Profit Up 69 Voluntarily Delist 69 Stronger Than Expected 69 Suit Filed 69 Posts Smaller 69 Cuts FY# 69 Shareholders Approve Merger Agreement 69 Anemia Drugs 69 Awarded Contract Extension 69 Profits Soar 69 Stands Behind 69 File Suit 69 Underscores Importance 69 Anticipates 69 Receives Waiver 69 Provides Unprecedented 69 Increases Dividend 69 Profit Beats Expectations 69 Expresses Confidence 69 Launches Probe Into 69 Q3 Profit Decreases 69 Revises FY# Outlook 69 Down Sharply 69 SABESP Announces 69 widens Quick Facts 69 4Q Profit Falls 69 Ink Deal 69 Sets Deadline 69 Reminds Shareholders 69 Reports Narrower 69 Technicals Showing Bearish 69 1Q Profit Slides 69 Drug Makers 69 Reports Sharply Higher 69 Lawsuits Filed 69 Probes Possible 69 Reiterates Fiscal 69 Announces Commencement 69 Posts Wider 69 Sounds Alarm 69 Improves Survival 69 Reaffirms Support 69 Hits Roadblock 69 Annual Meeting Date 69 Upcoming Deadline 69 Fall Sharply 69 Repositions 69 Announces Expiration 69 Mutually Agree 69 Liquidates 69 Expresses Support 69 Schedules 3Q 69 Host Third Quarter 69 Identifies Potential 69 Revises Earnings 69 Revises 69 Posts Narrower 69 Boosts Quarterly Dividend 69 Resolve Dispute 69 Expresses Concerns 69 Mulls Sale 69 Guidelines Issued 69 Revenue Grows 69 Judge Upholds 69 Finalizes Sale Of 69 Fine Tunes 69 Wins Dismissal 69 Announce Merger Agreement 69 Increases Quarterly 69 Reporting Requirements 69 Settles Suits 69 Lawmakers Seek 69 Broadens Scope 69 Approves Settlement 69 Alert Technicals Showing Bullish 69 Closes Acquisition Of 69 Earnings Scorecard 69 Settles Dispute With 69 Gains Traction 69 Resubmit 69 Lowers Estimates 69 Announces Dividend 69 Judge Nixes 69 Restructures Debt 69 Posts Wider 4Q Loss 69 Receives Highest Rating 69 3Q Profit Down 69 Gives Boost 69 Loss Widens 69 Adjourns 69 Completes Repurchase 69 3Q Profit Surges 69 Webcast Fourth Quarter 69 Files Motion 69 Rise Sharply 69 Anticipates Strong 69 Lupus Drug 69 Boosts Guidance 69 Reinforces Commitment 69 Ensure Compliance 69 Focuses Attention 69 Options Activity 69 Hits Snag 69 Lawsuit Targets 69 Beefs Up 69 Announces Shareholder Approval 69 Decides Against 69 Settles Dispute 69 Examines Impact 69 Loses Appeal 69 Recertified 69 Obtains Financing 69 Reduces Size 69 ISS Recommends 69 Shares Climb 69 Files Complaint 69 Expects 4Q 69 Wizzard Software Announces 68 Raises Concerns Over 68 Acquire Assets 68 Share Repurchases 68 Provides Update 68 Court Tosses 68 Gets Boost From 68 Considers Options 68 Weighs Options 68 Votes Unanimously 68 Suspends Quarterly Dividend 68 Receives CE Marking 68 Commends 68 Withdraws Offer 68 Eases Rules 68 Questions Remain About 68 Epilepsy Drug 68 Puts Pressure 68 Files Suit 68 Finalizes Agreement 68 CEO Exercises Options 68 Settle Dispute 68 Hits Lowest Level 68 Defers 68 Judge Dismisses Suit Against 68 Implant Sciences Announces 68 Declines Quick Facts 68 Sends Letter 68 Gets Favorable Ruling 68 Report Finds 68 Receives Requisite Consents 68 Loss Narrows 68 Extends Reach 68 Streamlines Operations 68 Reverses Loss 68 Puts Purchased 68 Deliver Comprehensive 68 Successfully Completed 68 Directors Authorizes Additional 68 Ups Bid 68 Presents Positive 68 RECOMMENDS THAT 68 Significantly Reduce 68 Boosts Productivity 68 Extends Contract 68 Shortchanges 68 Execs Say 68 Pulls Down 68 Pending Merger 68 Record Fourth Quarter 68 Awarded GSA Schedule 68 Taps Lobbyist 68 Seeks Answers 68 Stands Ready 68 Earnings Soar 68 FDA Warns 68 Nine Month 68 Takes Step Toward 68 Become Fully 68 Legislation Passes 68 1st Quarter Results 68 Revises Second Quarter